Mumbai, 23rd May, 2025: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Amlodipine and Atorvastatin Tablets USP, 2.5 mg/10 mg, 2.5 mg/20 mg, 2.5 mg/40 mg, 5 mg/10 mg, 5 mg/20 mg, 5 mg/40 mg, 5 […]
The post Alembic Pharma Secures USFDA Final Nod for Amlodipine and Atorvastatin Tablets first appeared on Business News Week.
Comments are closed